PharmaCyte Biotech (PMCB) Change in Inventory (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly Change in Inventory of -$9620.0 for Q4 2012, up 61.94% year-over-year from -$5940.4 in Q4 2011, and down 446.79% quarter-over-quarter from $2774.0 in Q3 2012.
PharmaCyte Biotech (PMCB) Change in Inventory (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Change in Inventory for 3 consecutive years, with -$9620.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Change in Inventory rose 61.94% year-over-year to -$9620.0; the TTM figure through Jul 2013 stood at -$9620.0 (up 52.32% YoY), while the FY2013 annual figure was -$6846.0, up 42.28% from the prior year.
- Change in Inventory slipped to -$9620.0 in Q4 2012 per PMCB's latest filing, from $2774.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $11089.0 in Q3 2011 and bottomed at -$25277.0 in Q4 2011.
- Historically, Change in Inventory has averaged -$3488.4 across 3 years, with a median of -$157.5 in 2010.
- On a YoY basis, Change in Inventory climbed as much as 1852.29% in 2011 and fell as far as 1389.64% in 2011.
- PharmaCyte Biotech's Change in Inventory stood at $1960.0 in 2010, then sank by 1389.64% to -$25277.0 in 2011, then jumped by 61.94% to -$9620.0 in 2012.
- Business Quant data shows PMCB's Change in Inventory at -$9620.0 in Q4 2012, $2774.0 in Q3 2012, and $4539.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -280,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 12.97 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 135.26 Mn |
| 10 | PharmaCyte Biotech | 4.30 Mn | 4.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -9,620.00 |
| Oct 31, 2012 | -9,620.00 |
| Jul 31, 2012 | 2,774.00 |
| Jul 31, 2012 | 2,774.00 |
| Apr 30, 2012 | 4,539.00 |
| Apr 30, 2012 | 4,539.00 |
| Jan 31, 2012 | -2,211.00 |
| Jan 31, 2012 | -2,211.00 |
| Oct 31, 2011 | -25,277.00 |
| Oct 31, 2011 | -25,277.00 |
| Jul 31, 2011 | 11,089.00 |
| Jul 31, 2011 | 11,089.00 |
| Apr 30, 2011 | -17,823.00 |
| Apr 30, 2011 | -17,823.00 |
| Jan 31, 2011 | -883.00 |
| Jan 31, 2011 | -883.00 |
| Oct 31, 2010 | 1,960.00 |
| Oct 31, 2010 | 1,960.00 |
| Jul 31, 2010 | 568.00 |
| Jul 31, 2010 | 568.00 |